Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues
Mots clés
cccDNA
closed circular DNA
CHMP
Committee for Medicinal Products for Human Use
EIA
enzyme immunoassay
EMA
European Medicines Agency
HBV
hepatitis B virus
HCV
hepatitis C virus
HDV
hepatitis D virus
IQR
interquartile range
NUCs
nucleoside and nucleotide analogues
pegIFN
pegylated interferon
RASs
resistance-associated substitutions
TAF
tenofovir alafenamide
Domaines
Sciences du Vivant [q-bio]
Origine : Publication financée par une institution